6911
In a Hoosier Oncology Group randomized study involving extensive - disease SCLC patients , VIP was superior to etoposide / cisplatin with regard to median time to progression ( 6 . 6 v 5 . 8 months ) , median survival times ( 9 . 1 v 7 . 3 months ) , and 2 - and 3 - year survival rates ( 13 % v 5 % and 5 % v 0 % , respectively ) .
 None
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: GENE 
Text: {0} 
 Entities:  
Answer:
 None